ArticleJournal of hematology & oncology2017

Phospho-Akt overexpression is prognostic and can be used to tailor the synergistic interaction of Akt inhibitors with gemcitabine in pancreatic cancer.

Daniela Massihnia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.